Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Profit After Tax: 2018-2022

Historic Profit After Tax for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2022 value amounting to -$155,800.

  • ADC Therapeutics' Profit After Tax rose 7.67% to -$46.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$36.2 million, marking a year-over-year increase of 72.47%. This contributed to the annual value of -$155,800 for FY2022, which is 32.27% up from last year.
  • Latest data reveals that ADC Therapeutics reported Profit After Tax of -$155,800 as of FY2022, which was up 32.27% from -$230,026 recorded in FY2021.
  • Over the past 5 years, ADC Therapeutics' Profit After Tax peaked at -$116,484 during FY2019, and registered a low of -$246,290 during FY2020.
  • Moreover, its 3-year median value for Profit After Tax was -$230,026 (2021), whereas its average is -$210,705.
  • Its Profit After Tax has fluctuated over the past 5 years, first slumped by 111.44% in 2020, then soared by 32.27% in 2022.
  • Yearly analysis of 5 years shows ADC Therapeutics' Profit After Tax stood at -$123,096 in 2018, then rose by 5.37% to -$116,484 in 2019, then plummeted by 111.44% to -$246,290 in 2020, then increased by 6.60% to -$230,026 in 2021, then soared by 32.27% to -$155,800 in 2022.